Table 1 Effectiveness of the intervention on different outcomes in the cascade of care
Measurements | Pre-trial intervention period (July–December 2017) | Intervention period of the trial (March–October 2018) | Follow-up study (November–March 2019) |
|---|---|---|---|
Number of index-TB patients | 41 | 57 | 38 |
Total number of HHCs identified (Number per 100 index-TB patients)a | 78 (190) | 142 (249) | 70 (184) |
Difference in number per 100 index-TB patients between follow-up study and earlier periods (95% CI) | −6 (− 47 to 34) | −65 (− 115 to − 15) | – |
Total number of HHCs initiating LTBI treatment (Number per 100 index-TB patients)a | 2 (5) | 28 (49) | 18 (47) |
Difference in number per 100 index-TB patients between follow-up study and earlier periods (95% CI) | 42 (22 to 63) | −2 (− 8 to 5) | – |